![[Podcast] Trial Trailblazers: Behind clinical breakthroughs](https://imgproxy.divecdn.com/cr_gUY8HHfHKWVfM5mEkCyXB9OzVqKd0L_Zq5ZJQSoM/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlX1BvZGNhc3RfY292ZXIxMzQ2eDcyOV9SMi5wbmc=.webp)
Abcuro hires ex-Alexion, Biohaven exec to lead commercial team ahead of planned launch
Abcuro has begun to add commercial muscle ahead of the anticipated launch of an inflammatory disease drug, appointing ex-Priovant Therapeutics executive Courtney Cupples to its C-suite to lead preparations.
Abcuro has begun to add commercial muscle ahead of the anticipated launch of an inflammatory disease drug, appointing ex-Priovant Therapeutics executive Courtney Cupples to its C-suite to lead preparations.
